Skip to main content
OpenTrials

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,207 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Influenza trial results

Completed

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

NCT04576702

Conditions
Human, Infections, Influenza, +6 more
Locations
  • 4022 - Coastal Clinical Research, an AMR company Mobile, Alabama, United States
  • 4002 - Clinical Research Consortium, an AMR company Tempe, Arizona, United States
  • 4006 - Westside Center for Clinical Research Jacksonville, Florida, United States
  • 4013 - Jacksonville Center for Clinical Research Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

NCT01006798

Conditions
Animal Diseases, Bird Diseases, Bird Flu, +9 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • The Center for Pharmaceutical Research Kansas City, Missouri, United States
  • University of Rochester Rochester, New York, United States
  • Coastal Carolina Research Center, Inc. Mt. Pleasant, South Carolina, United States
View Trial Details
Completed

Performance Evaluation of the Lucira COVID-19 & Flu Test

NCT06141824

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Benchmark Research Colton, California, United States
  • Carbon Health Oakland, California, United States
  • Koch Family Medicine Morton, Illinois, United States
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

NCT05585632

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations
  • Accel Research Sites DeLand, Florida, United States
  • Research Centers of America (cenexel) Hollywood, Florida, United States
  • Accel Research Sites St. Petersburg, Florida, United States
  • Atlanta Center for Medical Research - Family Medicine Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

NCT05375838

Conditions
Infections, Influenza, Influenza, Human, +6 more
Locations
  • Research Centers of America Hollywood, Florida, United States
  • AES - DRS - Optimal Research Illinois - Peoria Peoria, Illinois, United States
  • Meridian Sioux City, Iowa, United States
  • Benchmark Research Metairie, Louisiana, United States
View all 14 locations
View Trial Details
Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

NCT05734040

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
  • Emeritus Research Sydney Sydney, New South Wales, Australia
  • Paratus Clinical Research Western Sydney Sydney, New South Wales, Australia
  • Paratus Clinical Research Brisbane Brisbane, Queensland, Australia
View Trial Details

Related conditions